| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |